Atlas Trials

Effects of Oxytocin and Lorazepam on Fear-related Intra-amygdalar Activity

Clinical trial NCT03829839 · COMPLETED

Trial details

NCT number
NCT03829839
Sponsor
University Hospital, Bonn
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
Oxytocin, Lorazepam, Anti-Anxiety Agents, Physiological Effects of Drugs
Start date
2016-03-03
Primary completion
2017-08-16
Enrollment
120

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.